tiprankstipranks
CureVac on track with 30% workforce reduction
PremiumThe FlyCureVac on track with 30% workforce reduction
3M ago
CureVac sees cash runway into 2028
Premium
The Fly
CureVac sees cash runway into 2028
3M ago
Curevac N.V. (CVAC) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Curevac N.V. (CVAC) Q3 Earnings Cheat Sheet
3M ago
CDC confirms third human case of H5 bird flu in California
PremiumThe FlyCDC confirms third human case of H5 bird flu in California
4M ago
CureVac’s CVGBM Shows Promise in Glioblastoma Study
Premium
Company Announcements
CureVac’s CVGBM Shows Promise in Glioblastoma Study
5M ago
CureVac presents data from dose-escalation Part A of Phase 1 CVGBM vaccine study
Premium
The Fly
CureVac presents data from dose-escalation Part A of Phase 1 CVGBM vaccine study
5M ago
CureVac price target lowered to $16 from $18 at JMP Securities
PremiumThe FlyCureVac price target lowered to $16 from $18 at JMP Securities
6M ago
CureVac Secures Lucrative GSK Deal and Refocuses Business
Premium
Company Announcements
CureVac Secures Lucrative GSK Deal and Refocuses Business
6M ago
CureVac’s Rising Revenues Met With Increased Losses
Premium
Company Announcements
CureVac’s Rising Revenues Met With Increased Losses
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100